Inventor · disambiguated record
Marcel Van Gaalen
Also filed as: VAN GAALEN MARCEL
11 granted patents·4 pending applications·21 citations·filing 2010–2016
82Inventor score
Top patents by PatentIndex Score
15 records- 0188US9090592B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Jul 28, 2015·6 cites·29 claims
- 0286US9266855B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Feb 23, 2016·11 cites·22 claims
- 0383US9527856B2Oxindole compounds carrying a CO-bound spiro substituent and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2015·Granted Dec 27, 2016·4 cites·38 claims
- 0451US9540370B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 10, 2017·0 cites·28 claims
- 0551US9273036B2Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressine-related diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 1, 2016·0 cites·27 claims
- 0649US2016168135A1Oxindole derivatives carrying an oxetane substituent and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 0747US10100048B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2015·Granted Oct 16, 2018·0 cites·25 claims
- 0847US9862704B2Oxindole derivatives carrying an amine-substituted piperidyl-acetidinyl substituent and use thereof for treating vasopressine-related diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Jan 9, 2018·0 cites·30 claims
- 0947US2016194320A1Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 1046US9840495B2Oxindole derivatives carrying a piperidyl-substituted azetidinyl substituent and use thereof for treating vasopressine-related diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted Dec 12, 2017·0 cites·29 claims
- 1142US9657002B2Oxindole derivatives carrying an oxetane substituent and use thereof for treating vassopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2014·Granted May 23, 2017·0 cites·28 claims
- 1241US2013245038A1Method For Selecting Or Identifying A Subject For V1B Antagonist TherapyABBVIE DEUTSCHLAND·Filed 2013·Application pending·0 cites
- 1336US9688678B2Oxindole compounds carrying a nitrogen-bound spiro substituent and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2015·Granted Jun 27, 2017·0 cites·31 claims
- 1435US9617226B2Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseasesABBVIE DEUTSCHLAND·Filed 2015·Granted Apr 11, 2017·0 cites·29 claims
- 1535US2011059983A1Use of substituted oxindole derivatives for the treatment and prophylaxis of painABBOTT GMBH & CO KG·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →